journal article·2023-01Open access

Nanostructured Ag‐Bioglass Implant Coatings with Antibacterial and Osteogenic Activity

Felix J. Geissel, Varvara Platania, Niccoló DeBerardinis, Charlotte Skjöldebrand, Georgios N. Belibasakis, Cecilia Persson, Gry Hulsart‐Billström, Maria Chatzinikolaidou, Georgios A. Sotiriou

Advanced Materials Interfaces· Volume 10· Issue 3

Abstract

Abstract Bone implant failure due to aseptic loosening and biofilm infections is an increasing healthcare problem. Implants may be coated with nanoparticles to avoid bacterial colonization and promote osseointegration. However, these nanocoatings often require long, expensive, and complex manufacturing routes with limited clinical translation potential. Here, a multifunctional nanoparticle coating consisting of silver (Ag) and bioglass (BG) is investigated to overcome current limitations by providing synchronously antibacterial and osteogenic effect. Flame spray pyrolysis (FSP) is exploited as a scalable and reproducible process to synthesize large quantities of nanoparticles and deposit them on titanium (Ti) substrates. The deposited nanocoatings show a homogeneous morphology and biomineralize after soaking in simulated body fluid (SBF), while their adhesion on Ti substrates is promoted by in situ flame annealing. The Ag+ ion release from Ag containing BG samples inhibits Staphylococcus aureus biofilm formation up to 3 log units, while the osteogenic responses of pre‐osteoblastic cells directly grown on AgBG samples show similar levels of alkaline phosphatase activity, calcium and collagen production when compared to pure Ti. The inexpensively synthesized multifunctional AgBG nanostructured implant coatings exert a high bioactivity and antibacterial response while maintaining high biocompatibility. The insights of this study can direct the development of multifunctional implant coatings.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Microbiology Tumor and Cell Biology Karolinska Institutet Stockholm 171 76 Sweden

Department of Materials Science and Technology University of Crete Heraklion Greece

Department of Medicinal Chemistry Uppsala University Uppsala 751 05 Sweden

Department of Materials Science and Engineering Uppsala University Uppsala Sweden

Division of Oral Diseases Department of Dental Medicine Karolinska Institutet Stockholm 141 52 Sweden

Institute of Electronic Structure and Laser (IESL) Foundation for Research and Technology Hellas (FORTH) Heraklion Greece

Funding

European Research Council · Karolinska Institutet · Vetenskapsrådet · Hellenic Foundation for Research and Innovation · H2020 European Research Council

References (45)

Show source-provided references
1. 10.1038/nrmicro.2017.9910.1038/nrmicro.2017.99 ↗
2. 10.1007/978-3-319-11038-7_210.1007/978-3-319-11038-7_2 ↗
3. 10.1177/030006051773269710.1177/0300060517732697 ↗
4. 10.1016/j.biomaterials.2016.01.01610.1016/j.biomaterials.2016.01.016 ↗
5. 10.1016/j.otsr.2009.11.00410.1016/j.otsr.2009.11.004 ↗
6. 10.1177/088532820809546910.1177/0885328208095469 ↗
7. 10.3390/jfb901002510.3390/jfb9010025 ↗
8. 10.34133/2022/989627410.34133/2022/9896274 ↗
9. 10.1016/j.smaim.2021.08.00310.1016/j.smaim.2021.08.003 ↗
10. 10.3390/ma804139810.3390/ma8041398 ↗
11. 10.1007/s12633-017-9580-710.1007/s12633-017-9580-7 ↗
12. 10.1039/C9BM01924C10.1039/C9BM01924C ↗
13. Bartlett J. G. · Infect. Dis. Clin. Pract. · 2004 · 12 · 258
14. 10.1002/adma.20070184410.1002/adma.200701844 ↗
15. 10.1016/j.jcis.2021.11.03810.1016/j.jcis.2021.11.038 ↗
16. 10.1002/jbm.a.3547510.1002/jbm.a.35475 ↗
17. 10.1002/jbm.a.3552710.1002/jbm.a.35527 ↗
18. 10.1016/j.ijbiomac.2022.04.12910.1016/j.ijbiomac.2022.04.129 ↗
19. 10.1016/j.colsurfb.2016.10.02710.1016/j.colsurfb.2016.10.027 ↗
20. 10.1021/la901759p10.1021/la901759p ↗
21. 10.1016/j.apsusc.2005.09.06510.1016/j.apsusc.2005.09.065 ↗
22. 10.1039/C5RA25391H10.1039/C5RA25391H ↗
23. 10.1016/j.actbio.2012.07.00510.1016/j.actbio.2012.07.005 ↗
24. 10.1039/b517501a10.1039/b517501a ↗
25. 10.1021/es101072s10.1021/es101072s ↗
26. 10.1016/j.cej.2011.01.09910.1016/j.cej.2011.01.099 ↗
27. 10.1002/smll.20120212010.1002/smll.201202120 ↗
28. 10.1111/ijag.1500610.1111/ijag.15006 ↗
29. 10.1016/j.msec.2019.04.06010.1016/j.msec.2019.04.060 ↗
30. 10.1007/s10853-017-0781-710.1007/s10853-017-0781-7 ↗
31. 10.1039/c2sm00033d10.1039/c2sm00033d ↗
32. 10.1080/1040841X.2016.120814610.1080/1040841X.2016.1208146 ↗
33. 10.1021/la303370d10.1021/la303370d ↗
34. 10.1016/j.coche.2011.07.00110.1016/j.coche.2011.07.001 ↗
35. 10.1021/acsami.9b2019310.1021/acsami.9b20193 ↗
36. 10.1021/acsnano.7b0116610.1021/acsnano.7b01166 ↗
37. 10.1080/17435390.2018.143491010.1080/17435390.2018.1434910 ↗
38. 10.1039/C9NR08424J10.1039/C9NR08424J ↗
39. 10.3390/v1008043810.3390/v10080438 ↗
40. 10.1021/acs.molpharmaceut.1c0007710.1021/acs.molpharmaceut.1c00077 ↗
41. 10.1080/17460441.2019.158887910.1080/17460441.2019.1588879 ↗
42. 10.1016/j.jcis.2010.06.01910.1016/j.jcis.2010.06.019 ↗
43. 10.1016/j.surfcoat.2014.04.02810.1016/j.surfcoat.2014.04.028 ↗
44. 10.1016/j.bsecv.2021.04.00110.1016/j.bsecv.2021.04.001 ↗
45. 10.1089/ten.teb.2016.045410.1089/ten.teb.2016.0454 ↗